The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway

被引:101
|
作者
Wen, Zhenke [1 ]
Shen, Yi [1 ]
Berry, Gerald [2 ]
Shahram, Farhad [1 ]
Li, Yinyin [1 ]
Watanabe, Ryu [1 ]
Liao, Yaping Joyce [3 ]
Goronzy, Jorg J. [1 ]
Weyand, Cornelia M. [1 ]
机构
[1] Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; VASA VASORUM; DENDRITIC CELLS; POLYMYALGIA-RHEUMATICA; GATA3; EXPRESSION; UP-REGULATION; NOTCH; ARTERITIS; DIFFERENTIATION; ACTIVATION;
D O I
10.1126/scitranslmed.aal3322
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Microvascular networks in the adventitia of large arteries control access of inflammatory cells to the inner wall layers (media and intima) and thus protect the immune privilege of the aorta and its major branches. In autoimmune vasculitis giant cell arteritis (GCA), CD4 T helper 1 (TH1) and TH17 cells invade into the wall of the aorta and large elastic arteries to form tissue-destructive granulomas. Whether the disease microenvironment provides instructive cues for vasculitogenic T cells is unknown. We report that adventitial microvascular endothelial cells (mvECs) perform immunoregulatory functions by up-regulating the expression of the Notch ligand Jagged1. Vascular endothelial growth factor (VEGF), abundantly present in GCA patients' blood, induced Jagged1 expression, allowing mvECs to regulate effector T cell induction via the Notch-mTORC1 (mammalian target of rapamycin complex 1) pathway. We found that circulating CD4 T cells in GCA patients have left the quiescent state, actively signal through the Notch pathway, and differentiate into TH1 and TH17 effector cells. In an in vivo model of large vessel vasculitis, exogenous VEGF functioned as an effective amplifier to recruit and activate vasculitogenic T cells. Thus, systemic VEGF co-opts endothelial Jagged1 to trigger aberrant Notch signaling, biases responsiveness of CD4 T cells, and induces pathogenic effector functions. Adventitial microvascular networks function as an instructive tissue niche, which can be exploited to target vasculitogenic immunity in large vessel vasculitis.
引用
收藏
页数:15
相关论文
共 26 条
  • [21] BMP9 overexpressing adipose-derived mesenchymal stem cells promote cartilage repair in osteoarthritis-affected knee joint via the Notch1/Jagged1 signaling pathway
    Liu, Xinwei
    Du, Mingchang
    Wang, Yu
    Liu, Songbo
    Liu, Xianmin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 4623 - 4631
  • [22] LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathway
    Luo, Yun-Ya
    Wang, Zhi-Hua
    Yu, Qian
    Yuan, Ling-Li
    Peng, Hong-Ling
    Xu, Yun-Xiao
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [23] Mechanical stress up-regulates RANKL expression via the VEGF autocrine pathway in osteoblastic MC3T3-E1 cells
    Nakai, Takeshi
    Yoshimura, Yoshitaka
    Deyama, Yoshiaki
    Suzuki, Kuniaki
    Iida, Junichiro
    MOLECULAR MEDICINE REPORTS, 2009, 2 (02) : 229 - 234
  • [24] Activation of Notch-1 signaling pathway in macrophages to secrete PD-L1 and regulate cytotoxicity of CAR-T cells in diffuse large B-cell lymphoma
    Li, Weijing
    Wu, Lili
    Huang, Chen
    Ma, Hongqing
    Wang, Lianjing
    Liu, Wei
    Liu, Lihong
    AGING-US, 2024, 16 (02): : 1845 - 1859
  • [25] LINC00173 regulates polycystic ovarian syndrome progression by promoting apoptosis and repressing proliferation in ovarian granulosa cells via the microRNA-124-3p (miR-124-3p)/jagged canonical Notch ligand 1 (JAG1) pathway
    Chen, Lan
    Kong, Caixia
    BIOENGINEERED, 2022, 13 (04) : 10373 - 10385
  • [26] The Recombinant Eg.P29-Mediated miR-126a-5p Promotes the Differentiation of Mouse Naive CD4+ T Cells via DLK1-Mediated Notch1 Signal Pathway
    Du, Xiancai
    Zhu, Mingxing
    Zhang, Tingrui
    Wang, Chan
    Tao, Jia
    Yang, Songhao
    Zhu, Yazhou
    Zhao, Wei
    FRONTIERS IN IMMUNOLOGY, 2022, 13